Roivant Sciences Ltd. 8-K

What Happened
Roivant Sciences Ltd. announced and filed an 8-K on February 6, 2026 (Item 2.02) reporting its results of operations and financial condition for the fiscal quarter ended December 31, 2025. The company issued a press release with the quarterly results, which is attached to the filing as Exhibit 99.1.

Key Details

• Filing date: February 6, 2026; subject: Item 2.02 — Results of Operations and Financial Condition.
• Reporting period: fiscal quarter ended December 31, 2025.
• Press release with the quarterly results attached as Exhibit 99.1 to the Form 8-K.
• Form 8-K signed by Keyur Parekh as Authorized Signatory.

Why It Matters
This 8-K is the company’s official disclosure that it has released its latest quarterly earnings and related financial information. Investors should review the attached press release (Exhibit 99.1) for specific metrics such as revenue, net income (loss), and guidance, since the Form 8-K itself points to that press release as the source of the results. Timely review of the reported quarterly results can affect investment decisions and short-term trading around Roivant’s stock.